Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.20827 | 8 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.18917 | 8 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.19194 | 8 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.1396 | 8 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.13356 | 8 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.24404 | 8 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.2351 | 9 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.16463 | 8 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.15792 | 8 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.17519 | 8 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.17317 | 8 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.15565 | 8 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.18209 | 8 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.17763 | 8 |